(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KYSO KNOCK YOUR SOCKS OFF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

KYSO KNOCK YOUR SOCKS OFF

ST13

US500000079368784

Class

1, 5, 42, 45

Filing

79368784

Registration

7394274

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

03/21/2025

Trademark type

Combined

Nice classes

1, 5, 42, 45

Filing date

01/13/2023

Registration date

05/28/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/28/2024

Last transaction

05/28/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

65

Owner location

DK-2500 Valby, DK

Examiner

GULIANO, ROBERT

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of "KYSO" with the "K" in teal, the "Y" in teal and purple, the "S" in teal, and the "O" in teal, above "KNOCK YOUR SOCKS OFF" in grey.

Holders and representatives

Holders

Genmab A/S

Representatives

Max Vern Amster, Rothstein & Ebenstein LLP

Technical classification

Nice Classes

Class 1Class 5Class 42Class 45

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations for use in industry and science for in vitro and in vivo scientific and industrial research and development with regard to diseases; Biochemical preparations for in vitro and in vivo scientific research purposes with regard to diseases; biochemical reagents used for non-medical purposes in the nature of in vitro and in vivo scientific and industrial research with regard to diseases; chemicals for use in biotechnological product development in the nature of in vitro and in vivo industrial product development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cancerautoimmune diseasesinflammatory disorders

Class 5

- Pharmaceutical and veterinary preparations including preparations based on antibodiesbi- and multi-specific antibodies as well as fragmentsderivatives and conjugates thereofproducts for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system; Pharmaceutical and veterinary preparationsincluding preparations based on antibodiesbi- and multi- specific antibodies as well as fragmentsderivatives and conjugates thereoffor the treatment of cancerautoimmune diseasesinflammatory disorders

Class 42

Medicalscientific and biological research in the fields of antibodiesbi- and multi-specific antibodies as well as fragmentsderivatives and conjugates thereof and development of pharmaceutical products based on the same; chemical analysis; computer programmingprogramming of computers for the collection and processing of medical data for use in medical scientific researchdevelopment and therapy and scientific researchdevelopment and therapy with antibodies and bi- and multi- specific antibodies as well as fragmentsderivatives or conjugates of any of these

Class 45

Legal services relating to the exploitation of patents and licensing of intellectual property in the field of medicine

Publications

History of USPTO decisions and trademark events.

28 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/21/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/30/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/13/2024

FIMP

FINAL DISPOSITION PROCESSED

11/13/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/28/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/28/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

05/28/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/04/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/27/2024

PUBO

PUBLISHED FOR OPPOSITION

02/27/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/07/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/07/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/07/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/24/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/19/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/18/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/18/2024

RFNT

REFUSAL PROCESSED BY IB

11/13/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/25/2023

RFRR

REFUSAL PROCESSED BY MPU

10/25/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/17/2023

CNRT

NON-FINAL ACTION WRITTEN

10/16/2023

DOCK

ASSIGNED TO EXAMINER

10/11/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

09/15/2023

MAFR

APPLICATION FILING RECEIPT MAILED

05/09/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/05/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/04/2023

Continuous trademark protection

Get notified about every new filing that threatens KYSO KNOCK YOUR SOCKS OFF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.